Insulin? I don’t think that Manchin-connected company does anything with insulin? Probably not even with diabetes meds.
Anybody else know?
Try this one...
HERTFORDSHIRE, England and PITTSBURGH, March 10, 2020 /PRNewswire/ — Mylan N.V. (NASDAQ: MYL) today announced that the U.S. District Court of New Jersey found the device patent claims (U.S. Patent No. 9,526,844) asserted by Sanofi against Mylan’s insulin glargine product not infringed and invalid for lack of written description.